A 46,XX testicular disorder of sex development caused by a Wilms' tumour Factor-1 (WT1) pathogenic variant
Carregando...
Citações na Scopus
26
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
GOMES, Nathalia L.
PAULA, Leila C. P. de
SILVA, Juliana M.
SILVA, Thatiana E.
LERARIO, Antonio M.
NISHI, Mirian Y.
BATISTA, Rafael L.
Citação
CLINICAL GENETICS, v.95, n.1, p.172-176, 2019
Resumo
Molecular diagnosis is rarely established in 46,XX testicular (T) disorder of sex development (DSD) individuals with atypical genitalia. The Wilms' tumour factor-1 (WT1) gene is involved in early gonadal development in both sexes. Classically, WT1 deleterious variants are associated with 46,XY disorders of sex development (DSD) because of gonadal dysgenesis. We report a novel frameshift WT1 variant identified in an SRY-negative 46,XX testicular DSD girl born with atypical genitalia. Target massively parallel sequencing involving DSD-related genes identified a novel heterozygous WT1 c.1453_1456del; p.Arg485Glyfs*14 variant located in the fourth zinc finger of the protein which is absent in the population databases. Segregation analysis and microsatellite analysis confirmed the de novo status of the variant that is predicted to be deleterious by in silico tools and to increase WT1 target activation in crystallographic model. This novel and predicted activating frameshift WT1 variant leading to the 46,XX testicular DSD phenotype includes the fourth zinc-finger DNA-binding domain defects in the genetic aetiology of 46,XX DSD.
Palavras-chave
atypical genitalia, disorder of sex development, 46,XX testicular, WT1
Referências
- Ahn YH, 2017, PEDIATR NEPHROL, V32, P81, DOI 10.1007/s00467-016-3395-4
- Baetens D, 2017, GENET MED, V19, P367, DOI 10.1038/gim.2016.118
- Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467
- Bashamboo A, 2016, HUM MOL GENET, V25, P3446, DOI 10.1093/hmg/ddw186
- CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A
- Chen M, 2017, DEVELOPMENT, V144, P44, DOI 10.1242/dev.144105
- Delot E, 1993, NONSYNDROMIC
- Domenice S, 2016, BIRTH DEFECTS RES C, V108, P309, DOI 10.1002/bdrc.21145
- Eozenou C, 2017, WILMS TUMOR SUPPRESS
- FRASIER SD, 1964, J PEDIATR-US, V64, P740, DOI 10.1016/S0022-3476(64)80622-3
- Grinspon RP, 2016, SEX DEV, V10, P1, DOI 10.1159/000445088
- Hoefele J, 2017, NEPHRON, V135, P72, DOI 10.1159/000450709
- Knarston I, 2016, CLIN SCI, V130, P421, DOI 10.1042/CS20150579
- KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R
- Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570
- Ono M, 2013, NAT REV ENDOCRINOL, V9, P79, DOI 10.1038/nrendo.2012.235
- Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
- Takasawa K, 2014, FASEB J, V28, P2020, DOI 10.1096/fj.13-246108
- Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254
- Wang HD, 2015, SCI REP-UK, V5, DOI 10.1038/srep13983
- Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654
- Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213
- Zirn B, 2005, AM J KIDNEY DIS, V45, P1100, DOI 10.1053/j.ajkd.2005.03.013